Clinical Trials Logo

Filter by:
NCT ID: NCT01249404 Completed - Leg Spasticity Clinical Trials

Dysport® Adult Lower Limb Spasticity Study

Start date: March 2011
Phase: Phase 3
Study type: Interventional

The purpose of this research study is to assess the efficacy of Dysport® compared to placebo in improving muscle tone in hemiparetic subjects with lower limb spasticity due to stroke or traumatic brain injury.

NCT ID: NCT01249261 Completed - Clinical trials for Postmenopausal Women With Osteoporosis

Effect of Stopping Risedronate After Long Term Treatment on Bone Turnover

Start date: October 2001
Phase: Phase 3
Study type: Interventional

The effects of stopping long-term (7 years) and short term (2 years) risedronate therapy on BMD (bone mineral density) and BTMs (bone turnover markers) will be summarized.

NCT ID: NCT01248819 Completed - Clinical trials for Laparoscopic Cholecystectomy

Local Anesthetic Nebulization and Instillation for Pain Control After Laparoscopic Surgery

Start date: April 2008
Phase: Phase 3
Study type: Interventional

Studies evaluating intraperitoneal local anesthetic instillation for pain relief after laparoscopic procedures have provided conflicting results. This randomized, double-blind study was designed to assess the effects of a novel intraperitoneal local anesthetic administration technique using nebulization on pain relief after laparoscopic cholecystectomy.

NCT ID: NCT01248806 Completed - Clinical trials for Subjects at High Risk of Lung Cancer Due to Smoking

Continuous Observation of Smoking Subject

COSMOS
Start date: October 2004
Phase:
Study type: Observational

The purpose of this study is to offer annual low-dose spiral CT radiological examination for 5 years to 5000 volunteers from the general population who are considered to be at high risk of developing lung cancer.

NCT ID: NCT01248364 Completed - Clinical trials for Diabetes Mellitus, Type 2

A Study to Determine Acute (After First Dose) and Chronic (After 28 Days) Effects of Empagliflozin (BI 10773) on Pre and Postprandial Glucose Homeostasis in Patients With Impaired Glucose Tolerance and Type 2 Diabetes Mellitus and Healthy Subjects

Start date: November 2010
Phase: Phase 2
Study type: Interventional

An open-label, phase II study to assess the acute and chronic effects of empagliflozin (BI 10773)on fasting and postprandial glucose homeostasis in patients with IGT and type 2 diabetes mellitus and assess the acute effects of empagliflozin in healthy subjects.

NCT ID: NCT01248195 Completed - Schizophrenia Clinical Trials

Optimization of Treatment and Management of Schizophrenia in Europe

OPTIMISE
Start date: May 2011
Phase: Phase 4
Study type: Interventional

The purpose of the study is optimising current treatments in schizophrenia and explore novel therapeutic options for schizophrenia. The study intends to both address basic, but so far unanswered, questions in the treatment of schizophrenia and develop new interventions. It is expected that the project will lead to evidence that is directly applicable to treatment guidelines, and will identify potential mechanisms for new drug development.

NCT ID: NCT01248000 Completed - Clinical trials for Histologically Confirmed Classical Hodgkin Lymphoma According to the Current World Health Organisation Classification

The Use of FDG-PET in Patient With Hodgkin Lymphoma: a Population Based Study From Northern Italy

Start date: May 2009
Phase: N/A
Study type: Observational

Positron Emission Tomography (PET) represents a step forward in the definition of response to therapy in patients with Hodgkin Lymphoma (HL). In particular the use of PET for the early assessment of response has been described as the most important tool for predicting the risk of disease progression. As no data are available to support the use of early assessment of response for adapting and modifying subsequent treatment, the use of PET should be limited only to patients enrolled in clinical trials. Irrespective of recommendations PET scanning is included in the current management of patients with HL at baseline, mid treatment, end of treatment, and follow-up. So far no study has been performed to verify how PET is currently used in the clinical setting and to assess if and how results of PET scanning are used for supporting treatment and clinical decisions.

NCT ID: NCT01247935 Completed - Pain Clinical Trials

Electroacupuncture and Trancutaneous Electrical Nervous Stimulation (TENS) for Colonoscopy Analgesia

Start date: November 2010
Phase: N/A
Study type: Interventional

To compare the effectiveness of acupuncture and transcutaneous electrical nervous stimulation (TENS) in reducing patient's discomfort during colonoscopy

NCT ID: NCT01247857 Completed - Clinical trials for Laparoscopic Cholecystectomy

Local Anesthetic Nebulization for Pain Control After Laparoscopic Cholecystectomy

Start date: April 2008
Phase: Phase 3
Study type: Interventional

Intraperitoneal nebulization of local anesthetic is a novel approach to pain management after laparoscopy. Preoperative compared with postoperative administration of analgesia remains controversial. This randomized, double blind, placebo-controlled trial compared the analgesic efficacy of preoperative with postoperative peritoneal ropivacaine nebulization in patients undergoing elective laparoscopic cholecystectomy.

NCT ID: NCT01247675 Completed - Clinical trials for Growth Hormone Deficient Adults

A Safety, Pharmacokinetic and Pharmacodynamic Study of ACP-001 (TransCon PEG hGH) in Adults With Growth Hormone Deficiency

Start date: November 2010
Phase: Phase 2
Study type: Interventional

This study investigates the pharmacokinetic profile (PK) and pharmacodynamic response (PD) of three different doses of ACP-001 given once-a-week compared to one dose-level of an approved daily human growth hormone product over a period of 4 weeks (4 weekly administrations versus 28 daily administrations).